Hepatocellular carcinoma
Reviews
[키워드] accelerated
Anti-VEGF
approved
bevacizumab
biopsies
Cancer
Clinical practice
Combination
combination therapies
criteria
Diabetes Mellitus
Efficacy
Evidence
expected
FDA approval
HCC
Health
Hepatitis B virus
hepatitis C virus
Immunotherapy
impacted
incidence
information
inhibitor
Liver cancer
management
molecular
mutations
New
Non-invasive
outcome
Pathogenesis
Patient
phase III trial
regimens
risk factor
sorafenib
stages
steatohepatitis
syndrome
Therapies
therapy
tissue
translated
Trial
tyrosine kinase inhibitor
unique
West
[DOI] 10.1038/s41572-020-00240-3 [Article Type] Reviews
[DOI] 10.1038/s41572-020-00240-3 [Article Type] Reviews